Baebies, Inc.
Durham, NC
- UEI
- NZSZBQ9B84T1
- CAGE
- 71VL0
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 25 Alexandria Wy, Durham, NC 27703, USA
- Website
- baebies.com
- Founded
- 2014
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of a rapid, quantitative HIV-1 assay for viral load self-monitoring | National Institute of Allergy and Infectious Diseases | $299,427 | |
| Baebies defense health agency small business innovation research phase i development of a wide multiplexing,… | Defense Health Agency | $249,849 | |
| A rapid, point-of-care diagnostic to identify viable sexually transmitted infections, reduce overtreatment, and… | National Institute of Allergy and Infectious Diseases | $2,900,723 | |
| Sbir 057 sample-to-answer detection of hepatitis c virus | CDC Pittsburgh | $243,499 | |
| A simple multiplexed platform for self-administered HIV and hepatitis b testing | National Institute of Allergy and Infectious Diseases | $299,982 |
About Baebies, Inc.
Baebies, Inc. is a Durham, North Carolina-based medical diagnostic technology company specializing in advanced digital microfluidic testing platforms. The company focuses on developing innovative diagnostic solutions for various medical applications, primarily targeting infectious disease testing, pediatric care, and point-of-care diagnostics. As a for-profit organization and small business, Baebies, Inc. has consistently secured federal contracts and grants from agencies like the National Institute of Allergy and Infectious Diseases (NIAID), Centers for Disease Control and Prevention (CDC), and the Defense Health Agency to develop cutting-edge diagnostic technologies.
Through federal contract awards, Baebies, Inc. has primarily focused on developing Small Business Innovation Research (SBIR) Phase I projects centered on diagnostic platforms for infectious diseases. These contracts, which are predominantly total small business set-asides, include developing rapid, quantitative HIV-1 assays for viral load self-monitoring, multiplex diagnostic platforms for detecting various diseases, and point-of-care technologies for differentiating HIV infection from vaccine-induced seropositivity. The company has worked with multiple federal agencies, including NIAID, CDC, and the Defense Health Agency, to create innovative diagnostic solutions that address critical public health needs. Contract values have ranged from approximately $243,000 to $2.3 million, demonstrating the company's ability to secure substantial federal funding for advanced diagnostic research.
Baebies, Inc.'s federal grant awards have similarly focused on developing sophisticated diagnostic platforms, particularly in the areas of infectious disease and critical care monitoring. Notable grant projects include developing a rapid, point-of-care diagnostic to identify viable sexually transmitted infections, a near-patient low blood volume platform for evaluating coagulation in trauma patients, and a differential diagnostic panel for COVID-19 and common respiratory infections. These grants, primarily awarded by agencies like NIAID and the National Heart, Lung, and Blood Institute, have involved developing innovative digital microfluidic technologies that enable rapid, low-volume testing across various medical contexts. The company has also engaged in sub-award collaborations, such as a project with Trustees of Boston University focused on developing a diagnostic platform for neonatal bacteremia, further expanding its research capabilities and partnerships.
Quick answers
What is Baebies, Inc.'s UEI?
Baebies, Inc.'s Unique Entity ID (UEI) in SAM.gov is NZSZBQ9B84T1.
What is Baebies, Inc.'s CAGE code?
Baebies, Inc.'s CAGE code is 71VL0.
What is Baebies, Inc.'s primary NAICS code?
Baebies, Inc.'s primary NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing).
Where is Baebies, Inc. located?
Baebies, Inc.'s physical address in SAM.gov is 25 Alexandria Wy, Durham, NC 27703, USA.
Is Baebies, Inc. registered in SAM.gov?
Yes. Baebies, Inc.'s SAM.gov registration is active through May 4, 2027.
What is Baebies, Inc.'s most recent federal award?
Baebies, Inc.'s most recent federal contract award is Development of a rapid, quantitative HIV-1 assay for viral load self-monitoring (75N93025C00028), from National Institute of Allergy and Infectious Diseases, on September 1, 2025.
On GovTribe
See Baebies, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors